
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (WHICH FORMS PART OF DOMESTIC
This document does not constitute, or form part of, any offer or invitation to sell, allot or issue or any solicitation of any offer to purchase or subscribe for any securities, nor shall it (or any part of it) or the fact of its distribution form the basis of, or be relied upon in connection with, or act as any inducement to enter into, any contract or commitment for securities.
This document should not be distributed, published, reproduced or otherwise made available in whole or in part or disclosed by recipients to any other person and, in particular, should not be distributed to persons with addresses in
("
Results of Share Offer
Further to the announcement dated
As detailed in the Company's circular dated
Completion of the issue of the New Admission Shares remains subject to various conditions including, the passing of all resolutions at the Company's General Meeting on
The New Admission Shares, when issued and fully paid, will rank pari passu in all respects with the existing Ordinary Shares and will rank for all dividends or other distributions declared, made or paid after the date of issue.
Upon the issue of the New Admission Shares and the other share issues detailed in the Circular, NIU will hold 61,402,390 New Ordinary Shares which represent 60.3% of the enlarged share capital of the Company.
The Company will provide further updates in due course in respect of the satisfaction of the other conditions related to the issue of the New Admission Shares. The Company now expects Admission of the New Ordinary Shares to take place on or around
For further information, please contact:
CEO
|
|
Financial PR
|
|
Further information on the Company can be found on its website at: www.criticalmetals.co.uk
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the